Your browser doesn't support javascript.
loading
Combined Effects of Inflammatory Status and Carotid Atherosclerosis: A 12-Year Follow-Up Study.
Mayer, Florian J; Binder, Christoph J; Wagner, Oswald F; Schillinger, Martin; Minar, Erich; Mlekusch, Wolfgang; Tsiantoulas, Dimitris; Goliasch, Georg; Hoke, Matthias.
Afiliación
  • Mayer FJ; From the Department of Laboratory Medicine (F.J.M., C.J.B., O.F.W., D.T.), Division of Angiology, Department of Internal Medicine II (M.S., E.M., W.M., M.H.), and Division of Cardiology, Department of Internal Medicine II (G.G.), Medical University of Vienna, Austria. florian.mayer@meduniwien.ac.at.
  • Binder CJ; From the Department of Laboratory Medicine (F.J.M., C.J.B., O.F.W., D.T.), Division of Angiology, Department of Internal Medicine II (M.S., E.M., W.M., M.H.), and Division of Cardiology, Department of Internal Medicine II (G.G.), Medical University of Vienna, Austria.
  • Wagner OF; From the Department of Laboratory Medicine (F.J.M., C.J.B., O.F.W., D.T.), Division of Angiology, Department of Internal Medicine II (M.S., E.M., W.M., M.H.), and Division of Cardiology, Department of Internal Medicine II (G.G.), Medical University of Vienna, Austria.
  • Schillinger M; From the Department of Laboratory Medicine (F.J.M., C.J.B., O.F.W., D.T.), Division of Angiology, Department of Internal Medicine II (M.S., E.M., W.M., M.H.), and Division of Cardiology, Department of Internal Medicine II (G.G.), Medical University of Vienna, Austria.
  • Minar E; From the Department of Laboratory Medicine (F.J.M., C.J.B., O.F.W., D.T.), Division of Angiology, Department of Internal Medicine II (M.S., E.M., W.M., M.H.), and Division of Cardiology, Department of Internal Medicine II (G.G.), Medical University of Vienna, Austria.
  • Mlekusch W; From the Department of Laboratory Medicine (F.J.M., C.J.B., O.F.W., D.T.), Division of Angiology, Department of Internal Medicine II (M.S., E.M., W.M., M.H.), and Division of Cardiology, Department of Internal Medicine II (G.G.), Medical University of Vienna, Austria.
  • Tsiantoulas D; From the Department of Laboratory Medicine (F.J.M., C.J.B., O.F.W., D.T.), Division of Angiology, Department of Internal Medicine II (M.S., E.M., W.M., M.H.), and Division of Cardiology, Department of Internal Medicine II (G.G.), Medical University of Vienna, Austria.
  • Goliasch G; From the Department of Laboratory Medicine (F.J.M., C.J.B., O.F.W., D.T.), Division of Angiology, Department of Internal Medicine II (M.S., E.M., W.M., M.H.), and Division of Cardiology, Department of Internal Medicine II (G.G.), Medical University of Vienna, Austria.
  • Hoke M; From the Department of Laboratory Medicine (F.J.M., C.J.B., O.F.W., D.T.), Division of Angiology, Department of Internal Medicine II (M.S., E.M., W.M., M.H.), and Division of Cardiology, Department of Internal Medicine II (G.G.), Medical University of Vienna, Austria.
Stroke ; 47(12): 2952-2958, 2016 12.
Article en En | MEDLINE | ID: mdl-27803393
BACKGROUND AND PURPOSE: Inflammatory responses play a key role in atherogenesis. The aim of this study was to assess the prognostic value of hsCRP (high-sensitivity C-reactive protein) and to evaluate whether degree of carotid stenosis and serum levels of hsCRP jointly predict long-term mortality in asymptomatic patients with carotid atherosclerosis. METHODS: One thousand sixty-five patients with neurological asymptomatic carotid atherosclerosis as evaluated by duplex sonography were prospectively followed for cause-specific mortality. RESULTS: During a median of 11.81 years, a total of 549 deaths, including 362 cardiovascular deaths, were recorded. The risk of all-cause and cardiovascular mortality significantly increased in patients with elevated serum levels of hsCRP (the adjusted hazard ratio for cardiovascular mortality per increase of 1 mg/dL of hsCRP levels was 1.47; P<0.001). Patients with a high degree of carotid stenosis and increased hsCRP levels were particularly at risk of adverse outcome. Patients with carotid narrowing over 50% and hsCRP levels >0.29 mg/dL (=median) had nearly twice as high a risk of cardiovascular mortality compared with patients with carotid stenosis of <50% and hsCRP levels <0.29 mg/dL (adjusted hazard ratio 1.89; P<0.001). Improvement in risk stratification with combined assessment of carotid stenosis and hsCRP was confirmed by an improvement of the continuous net reclassification improvement with 18% for all-cause mortality and 15% for cardiovascular mortality compared with the degree of carotid stenosis alone (P<0.01). CONCLUSIONS: Measurement of hsCRP in combination with ultrasound investigations of the carotid arteries at a single time point provides additional prognostic information for patients with asymptomatic carotid atherosclerosis.
Asunto(s)
Palabras clave
Buscar en Google
Base de datos: MEDLINE Asunto principal: Proteína C-Reactiva / Enfermedades de las Arterias Carótidas / Estenosis Carotídea Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Stroke Año: 2016 Tipo del documento: Article País de afiliación: Austria
Buscar en Google
Base de datos: MEDLINE Asunto principal: Proteína C-Reactiva / Enfermedades de las Arterias Carótidas / Estenosis Carotídea Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Stroke Año: 2016 Tipo del documento: Article País de afiliación: Austria